HealthLynked Appoints New CMO, Elects Directors
Ticker: HLYK · Form: 8-K · Filed: Jun 26, 2024 · CIK: 1680139
| Field | Detail |
|---|---|
| Company | Healthlynked Corp (HLYK) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $120,000, $0.081 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, board-of-directors, governance
TL;DR
HealthLynked beefs up leadership with new CMO and board members.
AI Summary
HealthLynked Corp. announced on June 25, 2024, the appointment of Dr. Michael J. Riff as Chief Medical Officer and the election of Dr. Riff and Ms. Jennifer L. Johnson to its Board of Directors. The company also disclosed compensatory arrangements for these individuals, details of which are included in the filing.
Why It Matters
The appointment of a Chief Medical Officer and new directors can signal a strategic shift or expansion in the company's medical and governance focus.
Risk Assessment
Risk Level: low — This filing primarily concerns executive appointments and board changes, which are routine corporate governance events.
Key Players & Entities
- HealthLynked Corp. (company) — Registrant
- Dr. Michael J. Riff (person) — Appointed Chief Medical Officer and elected to Board of Directors
- Ms. Jennifer L. Johnson (person) — Elected to Board of Directors
- June 25, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer for HealthLynked Corp.?
Dr. Michael J. Riff has been appointed as the new Chief Medical Officer for HealthLynked Corp.
Who were elected to the Board of Directors of HealthLynked Corp.?
Dr. Michael J. Riff and Ms. Jennifer L. Johnson were elected to the Board of Directors of HealthLynked Corp.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 25, 2024.
What other information is disclosed regarding the new Chief Medical Officer and board members?
The filing discloses compensatory arrangements for Dr. Michael J. Riff and Ms. Jennifer L. Johnson.
In which state is HealthLynked Corp. incorporated?
HealthLynked Corp. is incorporated in Nevada.
Filing Stats: 747 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2024-06-26 16:00:22
Key Financial Figures
- $120,000 — ed that Mr. Crupi's base salary will be $120,000 per year, and that he will be eligible
- $0.081 — 's common stock at an exercise price of $0.081 that shall vest ratably on each of June
Filing Documents
- ea0208529-8k_health.htm (8-K) — 25KB
- ea020852901ex99-1_health.htm (EX-99.1) — 13KB
- 0001213900-24-056163.txt ( ) — 208KB
- hlyk-20240625.xsd (EX-101.SCH) — 3KB
- hlyk-20240625_lab.xml (EX-101.LAB) — 33KB
- hlyk-20240625_pre.xml (EX-101.PRE) — 22KB
- ea0208529-8k_health_htm.xml (XML) — 3KB
02 Departure of Directors or Certain
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Chief Operating Officer On June 25, 2024, HealthLynked Corp., a Nevada corporation (the " Company "), appointed William Crupi, age 35, as its Chief Operating Officer, effective immediately. Mr. Crupi has served as the Company's Operations Manager since April 2023. Mr. Crupi previously served as Area Manager for Quigley Eye Specialists and Business Manager at Eye Site of Tampa Bay, both where he managed daily operations of multiple medical facilities, and as an Executive Recruiter at Morisey-Dart Group, where he partnered with clients in identifying qualified candidates for difficult executive roles in the medical device, manufacturing, and engineering fields. The Company and Mr. Crupi have agreed that Mr. Crupi's base salary will be $120,000 per year, and that he will be eligible to participate in the benefit plans and programs generally available to the Company's employees. Mr. Crupi will also receive a 10-year stock option to purchase 300,000 shares of the Company's common stock at an exercise price of $0.081 that shall vest ratably on each of June 25, 2025, June 25, 2026 and June 25, 2027. There are no arrangements or understandings between Mr. Crupi and any other person pursuant to which he was selected for his position. In addition, there are no family relationships between Mr. Crupi and any directors or executive officers of the Company, and no transactions are required to be reported under Item 404(a) of Regulation S-K between Mr. Crupi and the Company.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Furnished as Exhibit 99.1 of this Current Report on Form 8-K is a press release issued by the Company with regard to Mr. Crupi's appointment as Chief Operating Officer. The press release shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in any such filing.
01. Financial Statements
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Exhibit Title or Description 99.1 Press Release dated June 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHLYNKED CORP. Date: June 26, 2024 /s/ David Rosal David Rosal Chief Financial Officer 2